Acetylmethadol
A synthetic opioid analgesic
| Acetylmethadol | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Acetylmethadol is a synthetic opioid analgesic that is chemically related to methadone. It is used primarily in the treatment of opioid dependence and is known for its long-acting properties. Acetylmethadol is a racemic mixture, meaning it contains two enantiomers, which are mirror images of each other.
Pharmacology
Acetylmethadol acts on the mu-opioid receptor in the central nervous system, producing effects similar to those of other opioids, such as analgesia, euphoria, and respiratory depression. Its long duration of action makes it suitable for use in opioid substitution therapy.
Synthesis and Structure
The chemical structure of acetylmethadol is similar to that of methadone, with the addition of an acetyl group. This modification affects its pharmacokinetics, allowing for a longer duration of action. The structural formula of acetylmethadol is depicted in the image on the right.
Clinical Use
Acetylmethadol is used in the management of opioid dependence, providing a longer-acting alternative to methadone. It is administered orally and is typically used in a controlled clinical setting. The drug helps to reduce withdrawal symptoms and cravings in individuals undergoing treatment for opioid addiction.
Side Effects
Common side effects of acetylmethadol include nausea, vomiting, constipation, and drowsiness. As with other opioids, there is a risk of addiction and overdose, particularly if the drug is not used as prescribed.
Regulation
Due to its potential for abuse and addiction, acetylmethadol is classified as a controlled substance in many countries. Its use is typically restricted to specific medical settings and requires careful monitoring by healthcare professionals.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD